Johnson & Johnson connected to Synthes Roche is reviewing its business in order to cut costs.
The Swiss drugmaker said that is in response to recent setbacks in the development of key drugs and because of rising pressures on prices from healthcare reforms.
The group did not provide any details on the size of cost reductions.
A Swiss newspaper has reported that thousands of Roche workers could lose their jobs in the cut backs over the next two years.
“In view of mounting pressures to curb healthcare costs – especially in the United States and Europe – together with recent developments in late-stage projects in the Roche pipeline, this initiative aims to adapt cost structures and accelerate productivity improvements group-wide,” Roche said.
More about: Pharmaceutical companies, SwitzerlandCopyright © 2012 euronews
Top Stories
Greek debt deal sparks protests and a strike
Their political leaders may be breathing a sigh of relief. However, Greeks protesting outside parliament are far from happy that…
Deadly shelling continues in Homs
In Syria, the heavy bombardment of opposition-held neighbourhoods in Homs is reportedly…
Spain's 'human rights' judge Garzón convicted
Spain’s best-known judge, who achieved international fame for his human rights…
Corporate news
Renault’s low-cost Moroccan factory upsets politicians- Pepsi cuts jobs, boosts marketing chasing Coke
- Southern Europe hanging up on Vodafone
- Some shareholders baulk at Glencore-Xstrata merger
- Upbeat forecast from Toyota
- Gloomy outlook from UBS
- Boeing plays down 787 delamination problem
- Mitsubishi puts the brakes on European production
- Panasonic joins Sony and Sharp in sea of red ink
- Debt grounds Hungary’s Malev
euronews on facebook
